Zhibao Technology, a NASDAQ-listed insurtech company, announced a non-binding term sheet with Joyer Tech for a $4 billion Bitcoin-backed private investment in public equity (PIPE) financing. This amount is roughly 135 times Zhibao's recent half-year revenue, highlighting the ambitious nature of the deal. The announcement comes shortly after Zhibao received a NASDAQ deficiency notice for its stock price falling below $1, triggering a 180-day compliance period to avoid delisting. Investors should watch for SEC filings to confirm the deal and scrutinize Joyer Tech's background, as the financing structure and counterparties are unusual and could attract regulatory attention.
Benchmark has reiterated its Buy rating for Coinbase, highlighting the company's expansion of its "Everything Exchange" platform, which aims to integrate various trading activities into one system. Coinbase is also pursuing international growth, nota...
GE Vernova reported Q2 2026 earnings with an EPS of $2.47, missing the consensus estimate of $3.17, while revenue rose 22% year-over-year to $11.10 billion, beating expectations. Despite strong top-line growth and an upgraded full-year outlook, share...
Packaging Corporation of America is set to release its Q2 2026 earnings on July 22, with analysts expecting revenue of $2.40 billion, a 10.7% increase from last year, driven by higher packaging volume and pricing. However, earnings per share are fore...
The global automotive pumps market is projected to grow from $31.11 billion in 2026 to $34.15 billion by 2035, at a CAGR of 1.0%. Growth is driven by increased pump content in passenger cars, especially for engine and HVAC systems, as OEMs adopt adva...
Celldex Therapeutics lowered its price target from $67 to $61 after stopping its Phase 2 trial for barzolvolimab, a drug for prurigo nodularis, because it failed to meet primary efficacy goals. Despite this setback, the drug showed a strong safety pr...
